Coherus Oncology (CHRS) Prepaid Assets (2013 - 2026)

Coherus Oncology has disclosed Prepaid Assets across 14 years of filings, most recently posting $2.3 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $2.3 million, down 67.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 67.1% YoY), and the FY2025 annual result was $6.8 million, up 2.21% from the prior year.
• Prepaid Assets came in at $2.3 million for Q1 2026 at Coherus Oncology, down from $6.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $23.7 million in Q4 2023 to a low of $2.3 million in Q1 2026.
• The 5-year median for Prepaid Assets is $9.2 million (2024), against an average of $12.3 million.
• Across the five-year window, Prepaid Assets jumped 145.26% in 2023 and sank 71.93% in 2024, its largest moves.
• Coherus Oncology's Prepaid Assets stood at $22.9 million in 2022, then increased by 3.41% to $23.7 million in 2023, then slumped by 71.93% to $6.7 million in 2024, then rose by 2.21% to $6.8 million in 2025, then sank by 66.57% to $2.3 million in 2026.
• The last three Prepaid Assets figures came in at $2.3 million (Q1 2026), $6.8 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.